Expertise in
10
conditions

Samuel I. Pascual

La Paz, MD, ES 
Expertise in
10
conditions
La Paz, MD, ES 

Overview

Samuel Pascual practices practicing medicine in La Paz, Spain.

Mr. Pascual is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Primary Lateral Sclerosis, Limb-Girdle Muscular Dystrophy Type 2A, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

La Paz, MD, Spain
Other Locations
Madrid, MD, Spain
Castellana, MD 28046, Spain
UPF
Barcelona, CT, Spain
Valencia, VC, Spain
Bunyola, PM, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: Autologous Erythrocytes, Dexamethasone Sodium Phosphate
Study Phase: Phase 3
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
View 1 Less Clinical Trial

63 Total Publications

Epilepsy, neuroinflammation and cannabidiol What do we know thus far?
Epilepsy, neuroinflammation and cannabidiol What do we know thus far?
Journal: Frontiers in pharmacology
Published: November 18, 2025

Frequently Asked Questions about Samuel I. Pascual

Is Samuel I. Pascual a top-rated expert for Primary Lateral Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Samuel I. Pascual is classified as an Advanced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Samuel I. Pascual participate in research or clinical trials?

Yes. Samuel I. Pascual has published 63 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Samuel I. Pascual's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pascual's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 33 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile